Sintx Technologies, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Sintx Technologies, Inc. (SINT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $6.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-03-20
- Sintx Technologies, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $6.00K, a 200.00% increase from fiscal 2024.
- Sintx Technologies, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $2.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $6.00K 10-K · filed 2026-03-20 |
| 2024-12-31 | $2.00K 10-K · filed 2026-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |